Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines - Wikidata - wikimedia - TriplyDB

Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines

Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines

http://www.wikidata.org/entity/Q33855708

about

Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B.Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients.Virological response to adefovir monotherapy and the risk of adefovir resistance The clinical and laboratory characteristics of patients with chronic hepatitis B using current or past antiviral therapy in Korea: a multi-center, nation-wide, cross-sectional epidemiologic study.Safety and efficacy of entecavir in adefovir-experienced patients.No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B.Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study.Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease.

P2860

Q34024728-31863827-48B1-4951-A010-3266E6679F18 Q35152367-2DF63218-1E73-4DD9-956A-EF22BC47BBB3 Q35185125-CCDA9606-10BA-4B65-89D9-2AB116B42E7B Q35931235-FA7A43CC-0307-4CD9-8B39-D9B1CE6F9FBF Q42196672-3353BF76-B785-4879-81F9-2E6278607E02 Q42277100-593B6855-B6C6-4888-8308-0C0DE0A1067E Q45254370-49DFFE4E-1CD5-4220-ABEC-9A7F1C88B8B4 Q53390652-2C377BE7-1E1A-47A9-8459-165E501190AB

P2860

Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines

http://www.wikidata.org/entity/Q33855708

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Management of chronic hepatiti ...... a review of current guidelines

@ast

Management of chronic hepatiti ...... a review of current guidelines

@en

type

label

Management of chronic hepatiti ...... a review of current guidelines

@ast

Management of chronic hepatiti ...... a review of current guidelines

@en

prefLabel

Management of chronic hepatiti ...... a review of current guidelines

@ast

Management of chronic hepatiti ...... a review of current guidelines

@en

P1433

Q33855708-589574EE-9D81-4FB3-B13E-902BE4B57E3B

P1476

Q33855708-F23299D3-619D-4634-9BF9-F8AD67E63987

P2093

Q33855708-0EA304DB-1C63-4F57-AB76-A4D916899EFC

Q33855708-B5D27B89-5182-48CB-A33F-F0D186A0D47C

P2860

Q33855708-08810634-D0A9-481A-BBEE-55BD177EC2C8

Q33855708-0B5EB604-E439-48C8-9981-93D7CBAAB771

Q33855708-1A7BA07F-C14A-4078-A0F6-55FE5DED40FB

Q33855708-1FE1BEF9-9BF8-4A44-B3AF-BCEDBA8B6E37

Q33855708-21AA826C-A5A1-42C6-954E-22331598AFA5

Q33855708-21D711CC-5D72-49E9-A75C-245E9391BA03

Q33855708-28CF2D01-C1CA-4F7D-9823-190FB000F988

Q33855708-2D54F3D2-C22B-4213-ADD6-B4B692A9D8A2

Q33855708-3053AED0-3923-4863-BDEE-CFE491CCCCD7

Q33855708-42E874A5-4B92-4F6D-AE72-C15043174969

P304

Q33855708-D3854B2F-C11A-4B14-AD5C-2AC76CCAC5EA

P31

Q33855708-A6DE6D30-EBB9-4E06-898F-17CBA75BD9B7

P356

Q33855708-F0A6EBCC-00A0-4481-B939-E098AF9BB9DE

P433

Q33855708-849B4B3D-E57C-41FB-A713-171E0B04E14B

P478

Q33855708-352BFFDE-3D27-4401-9A2F-3DEEBB145CCD

P577

Q33855708-26581277-92BD-4382-8EF9-FFFC2DAFB8CA

P5875

Q33855708-0B3EC1E9-2215-4E34-B197-B70185CBA0E5

P698

Q33855708-D60BA419-6D7C-4BE6-AEBB-C423707D65BD

P932

Q33855708-FAA65108-4AB7-46AE-A2E9-F6FE538D1EA0

P356

GNL.2010.4.1.15

P1433

P1476

Management of chronic hepatiti ...... a review of current guidelines

@en

P2093

Byung Chul Yoo

http://www.w3.org/2001/XMLSchema#string

Moon Seok Choi

http://www.w3.org/2001/XMLSchema#string

P2860

The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance

Chronic hepatitis B: update 2009

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points.

Management of hepatitis B: 2000--summary of a workshop.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

The clinical significance of persistently normal ALT in chronic hepatitis B infection.

P304

15-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5009/GNL.2010.4.1.15

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44608876

http://www.w3.org/2001/XMLSchema#string

P698

20479908

http://www.w3.org/2001/XMLSchema#string

P932

2871615

http://www.w3.org/2001/XMLSchema#string